23andMe has filed documents with the SEC stating that it has raised $79 million of a $150 million round. The fundraising comes soon after the company revealed plans to dive into the drug development world, recruiting Genentech’s Richard Scheller as its chief scientific officer.

…read more

Source: 23andMe raises $79M as it ramps up R&D work


0 No comments